Levy S - Search Results

1

Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.

Weiss J, Menter A, Hevia O, Jones T, Ling M, Rist T, Roberts J, Shavin JS, Sklar J, Webster G, Connolly M, Furst K, Levy S. Weiss J, et al. Among authors: levy s. Cutis. 2002 Aug;70(2 Suppl):22-9. Cutis. 2002. PMID: 12353677 Clinical Trial.

2

Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.

Jorizzo J, Weiss J, Furst K, VandePol C, Levy SF. Jorizzo J, et al. Arch Dermatol. 2004 Jul;140(7):813-6. doi: 10.1001/archderm.140.7.813. Arch Dermatol. 2004. PMID: 15262691 Clinical Trial.

3

Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.

Jorizzo J, Stewart D, Bucko A, Davis SA, Espy P, Hino P, Rodriguez D, Savin R, Stough D, Furst K, Connolly M, Levy S. Jorizzo J, et al. Among authors: levy s. Cutis. 2002 Dec;70(6):335-9. Cutis. 2002. PMID: 12502122 Clinical Trial.

4

A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream.

Levy S, Furst K, Chern W. Levy S, et al. Cutis. 2002 Aug;70(2 Suppl):14-21. Cutis. 2002. PMID: 12353676

5

Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.

Loven K, Stein L, Furst K, Levy S. Loven K, et al. Among authors: levy s. Clin Ther. 2002 Jun;24(6):990-1000. doi: 10.1016/s0149-2918(02)80012-1. Clin Ther. 2002. PMID: 12117087 Clinical Trial.

6

A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis.

Levy S, Furst K, Chern W. Levy S, et al. Clin Ther. 2001 Jun;23(6):908-20. doi: 10.1016/s0149-2918(01)80078-3. Clin Ther. 2001. PMID: 11440290 Clinical Trial.

7

A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.

Tschen EH, Katz HI, Jones TM, Monroe EW, Kraus SJ, Connolly MA, Levy SF. Tschen EH, et al. Among authors: levy sf. Cutis. 2001 Feb;67(2):165-9. Cutis. 2001. PMID: 11236229 Clinical Trial.

8

A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation.

Levy S, Furst K, Chern W. Levy S, et al. Clin Ther. 2001 Jun;23(6):901-7. doi: 10.1016/s0149-2918(01)80077-1. Clin Ther. 2001. PMID: 11440289

9

A randomized, parallel, vehicle-controlled comparison of two erythromycin/benzoyl peroxide preparations for acne vulgaris.

Thiboutot D, Jarratt M, Rich P, Rist T, Rodriguez D, Levy S. Thiboutot D, et al. Among authors: levy s. Clin Ther. 2002 May;24(5):773-85. doi: 10.1016/s0149-2918(02)85151-7. Clin Ther. 2002. PMID: 12075945 Clinical Trial.

10

Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.

Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Leyden JJ, et al. Among authors: levy sf. Am J Clin Dermatol. 2001;2(1):33-9. doi: 10.2165/00128071-200102010-00006. Am J Clin Dermatol. 2001. PMID: 11702619 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,331 results

Search Page

Filters